Explainable stroke AI cleared for US sales

The FDA has OK’d an explainable AI platform for quickly diagnosing stroke on unenhanced CT scans.

Brainomix of Oxford, England, announced the clearance of its 360 e-Aspects tool March 21, noting it’s now in use across more than 30 countries.

The company says the product, named for the Alberta Stroke Program Early CT Score system, uses AI to automatically generate an Aspects score. The score displays on a heatmap laid over the imaging to help physicians visualize the nature and extent of ischemic changes.

Brainomix cites recent studies showing the software reduced diagnostic turnaround times by more than an hour in research settings.

The company says the result was the tripling of stroke patients who achieved functional independence and a 50%+ bounce in rates of effective thrombolysis and thrombectomy.

Brainomix CEO and co-founder Michalis Papadakis, PhD, says the ability to reliably diagnose stroke quickly and without contrast “carries particular clinical value for primary stroke centers, where there may not be around-the-clock specialist expertise but where most stroke patients are first admitted.”

He adds that the technology supports physicians “who are making time-sensitive, critical decisions around transfer and treatment, strengthening networks and facilitating an improved stroke service.”   

Brainomix has a field team at the ready in the U.S. to familiarize stroke-center clinicians with the newly approved platform as well as supply ongoing support.

Earlier this year, the company announced a strategic partnership with Blackford, which will distribute the software across its network.

Brainomix notes the Aspects scoring system was created by company co-founder Alastair Buchan, MD, a neurologist and professor of stroke medicine at the University of Oxford.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Trimed Popup
Trimed Popup